UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000030139
Receipt number R000034416
Scientific Title Double-Blind, parallel-group comparison, investigators initiated phase II clinical trial of IDEC-C2B8 (Rituximab) in patients with Systemic Sclerosis
Date of disclosure of the study information 2017/11/28
Last modified on 2020/09/29 20:40:20

No. Disposal Last modified on Item of update
1 Insert 2017/11/27 19:46:10
2 Update 2017/11/27 22:21:28 Acronym
Acronym
3 Update 2018/01/18 16:44:26 Recruitment status
4 Update 2018/01/18 16:57:30 Organization
Organization
Organization
Co-sponsor
Co-sponsor
Name of secondary funder(s)
Name of secondary funder(s)
5 Update 2018/11/29 13:46:51 Key inclusion criteria
Key inclusion criteria
6 Update 2018/11/29 13:49:20 Recruitment status
7 Update 2019/04/01 07:19:28 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
TEL
Email
Organization
Organization
Address
Address
Tel
Email
8 Update 2019/05/29 11:51:38 Email1
Email
9 Update 2019/11/06 11:51:10 Acronym
Scientific Title:Acronym
10 Update 2020/09/29 20:40:20 Recruitment status
Date of IRB
Last follow-up date